MD3286209T2 - Metodă de producere a gonadotrofinei - Google Patents

Metodă de producere a gonadotrofinei

Info

Publication number
MD3286209T2
MD3286209T2 MDE20180206T MDE20180206T MD3286209T2 MD 3286209 T2 MD3286209 T2 MD 3286209T2 MD E20180206 T MDE20180206 T MD E20180206T MD E20180206 T MDE20180206 T MD E20180206T MD 3286209 T2 MD3286209 T2 MD 3286209T2
Authority
MD
Moldova
Prior art keywords
gonadotrophin
production
host cell
hcg
genome
Prior art date
Application number
MDE20180206T
Other languages
English (en)
Inventor
Daniel Plaksin
Ayelet Grinhut
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of MD3286209T2 publication Critical patent/MD3286209T2/ro

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1081—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/99—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
    • C12Y204/99004—Beta-galactoside alpha-2,3-sialyltransferase (2.4.99.4)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41—Glycosylation, sialylation, or fucosylation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

O celulă gazdă caracterizată prin aceea că cuprinde în genomul său o secvenţă care codifică un lanţ de hCG şi utilizarea celulei gazdă pentru a produce hCG recombinant.
MDE20180206T 2015-04-24 2016-04-22 Metodă de producere a gonadotrofinei MD3286209T2 (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15164965 2015-04-24
PCT/EP2016/059006 WO2016170113A1 (en) 2015-04-24 2016-04-22 Method of production of gonadotrophin

Publications (1)

Publication Number Publication Date
MD3286209T2 true MD3286209T2 (ro) 2021-04-30

Family

ID=53002568

Family Applications (1)

Application Number Title Priority Date Filing Date
MDE20180206T MD3286209T2 (ro) 2015-04-24 2016-04-22 Metodă de producere a gonadotrofinei

Country Status (32)

Country Link
US (1) US10464984B2 (ro)
EP (1) EP3286209B1 (ro)
JP (1) JP6964519B2 (ro)
KR (1) KR102658666B1 (ro)
CN (2) CN114107315A (ro)
AU (1) AU2016251314B2 (ro)
BR (1) BR112017016895A2 (ro)
CA (1) CA2975449A1 (ro)
CL (1) CL2017002661A1 (ro)
CO (1) CO2017011964A2 (ro)
DK (1) DK3286209T3 (ro)
EA (1) EA034022B1 (ro)
ES (1) ES2837111T3 (ro)
HK (1) HK1246325A1 (ro)
HR (1) HRP20201945T1 (ro)
HU (1) HUE051879T2 (ro)
IL (1) IL253694B (ro)
LT (1) LT3286209T (ro)
MA (1) MA41949B1 (ro)
MD (1) MD3286209T2 (ro)
MX (1) MX2017010884A (ro)
MY (1) MY185823A (ro)
PH (1) PH12017501585A1 (ro)
PT (1) PT3286209T (ro)
RS (1) RS61163B1 (ro)
SA (1) SA517390029B1 (ro)
SG (1) SG11201706832PA (ro)
SI (1) SI3286209T1 (ro)
TN (1) TN2017000328A1 (ro)
UA (1) UA124187C2 (ro)
WO (1) WO2016170113A1 (ro)
ZA (1) ZA201707136B (ro)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020003379A2 (pt) 2017-09-01 2020-08-25 Ferring B.V. usos de hormônio folículo-estimulante recombinante (fsh) para estimulação ovariana controlada
CN108264549A (zh) * 2018-03-29 2018-07-10 北京伟杰信生物科技有限公司 重组绒促性素rhCG的制备方法及应用
TW201945024A (zh) 2018-04-30 2019-12-01 荷蘭商菲林公司 用於經控制之卵巢刺激的組成物
CN110812366B (zh) * 2019-11-18 2023-11-17 珠海丽凡达生物技术有限公司 一种可用于激素补充的mRNA药物及其制备方法
CN113337562B (zh) * 2021-05-24 2022-06-03 宁波人健药业集团股份有限公司 使用CHO细胞高效发酵生产rhCG的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6855544B1 (en) 1999-04-15 2005-02-15 Crucell Holland B.V. Recombinant protein production in a human cell
WO2001058493A1 (en) * 2000-02-11 2001-08-16 Maxygen Aps Conjugates of follicle stimulating hormones
US20030036181A1 (en) 2000-06-30 2003-02-20 Okkels Jens Sigurd Peptide extended glycosylated polypeptides
CN1194016C (zh) * 2000-12-29 2005-03-23 申庆祥 新的人绒毛膜***－促黄体素融合蛋白及其制法和用途
CN101250531B (zh) * 2006-11-27 2013-04-24 株式会社Lg生命科学 一核苷酸序列、包含该序列的表达载体、该载体转化的动物细胞及利用该细胞生产人fsh的方法
TWI604850B (zh) 2009-10-05 2017-11-11 菲瑞茵國際中心股份有限公司 藥學製劑
US8326547B2 (en) * 2009-10-07 2012-12-04 Nanjingjinsirui Science & Technology Biology Corp. Method of sequence optimization for improved recombinant protein expression using a particle swarm optimization algorithm
CA2784861A1 (en) * 2009-12-21 2011-07-14 Pharmathene, Inc. Recombinant butyrylcholinesterases and truncates thereof
JP2015518705A (ja) * 2012-04-02 2015-07-06 モデルナ セラピューティクス インコーポレイテッドＭｏｄｅｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． ヒト疾患に関連する生物製剤およびタンパク質の産生のための修飾ポリヌクレオチド
DE18200782T1 (de) 2012-04-02 2021-10-21 Modernatx, Inc. Modifizierte polynukleotide zur herstellung von proteinen im zusammenhang mit erkrankungen beim menschen
CN103539862B (zh) * 2013-11-01 2015-04-01 广州联康生物科技有限公司 一种长效重组促卵泡激素及其应用

Also Published As

Publication number Publication date
SI3286209T1 (sl) 2021-01-29
EA201791724A1 (ru) 2018-04-30
IL253694B (en) 2021-09-30
PT3286209T (pt) 2020-12-04
US20180127477A1 (en) 2018-05-10
RS61163B1 (sr) 2021-01-29
EA034022B1 (ru) 2019-12-19
CL2017002661A1 (es) 2018-03-23
SG11201706832PA (en) 2017-09-28
ES2837111T3 (es) 2021-06-29
MA41949A (fr) 2018-02-28
HK1246325A1 (zh) 2018-09-07
AU2016251314A1 (en) 2017-08-17
CA2975449A1 (en) 2016-10-27
CN107532172A (zh) 2018-01-02
DK3286209T3 (da) 2020-12-21
HUE051879T2 (hu) 2021-03-29
CN114107315A (zh) 2022-03-01
LT3286209T (lt) 2021-02-25
KR102658666B1 (ko) 2024-04-17
US10464984B2 (en) 2019-11-05
KR20170138390A (ko) 2017-12-15
ZA201707136B (en) 2022-03-30
JP2018512885A (ja) 2018-05-24
PH12017501585A1 (en) 2018-02-05
EP3286209A1 (en) 2018-02-28
HRP20201945T1 (hr) 2021-02-05
MA41949B1 (fr) 2020-12-31
MX2017010884A (es) 2017-12-07
IL253694A0 (en) 2017-09-28
WO2016170113A1 (en) 2016-10-27
BR112017016895A2 (pt) 2018-03-27
MY185823A (en) 2021-06-11
AU2016251314B2 (en) 2019-12-05
TN2017000328A1 (en) 2019-01-16
EP3286209B1 (en) 2020-11-25
JP6964519B2 (ja) 2021-11-10
UA124187C2 (uk) 2021-08-04
CO2017011964A2 (es) 2018-03-09
SA517390029B1 (ar) 2021-04-04

Similar Documents

Publication Publication Date Title
IL272710B (en) Using cell-free DNA fragment size to determine copy number variations
MD3286209T2 (ro) Metodă de producere a gonadotrofinei
HK1244844B (zh) 使用無細胞dna片段尺寸來確定拷貝數變異
CL2016002766A1 (es) Conector piramidal electrónico.
TR201909037T4 (tr) Yeni protein deamidaz.
UA122767C2 (uk) Ацильований аналог глюкагону
MX2015003552A (es) Comunicaciones de maniobra de emergencia de un vehiculo.
MX2016009437A (es) Metodo para reducir la produccion de gas total y/o la produccion de metano en un animal rumiante.
TWD167955S (zh) 生物感測器之部分
ECSP15043422A (es) Un procedimiento para aumentar la formacion de acido piroglutamico de una proteina
EA201590994A1 (ru) Способ увеличения гидродинамического объема полипептида путем присоединения карбоксиконцевого пептида гонадотропина
EA201791424A1 (ru) Получение белка
BR112016017402A2 (pt) fusões anti-pcsk9~glp-1 e métodos para uso
MX367638B (es) Metodo y aparato para controlar modo de dispositivo.
MY183321A (en) Microorganism producing o-acetyl-homoserine and method for producing o-acetylhomoserine using the same
EA201591720A1 (ru) Белки, специфические по отношению к baff и b7rp1, и их применение
AR096879A1 (es) Diutano como modificador de la reología en cementos sorel
TW201614530A (en) Method for modeling a photoresist profile
TR201907719T4 (tr) Kemik vida.
TR201905145T4 (tr) Diamin üreten mikroorganizma ve bunu kullanarak diamin üretimine yönelik yöntem.
AU359035S (en) Computer terminal
BR112017016626A2 (pt) micro-organismo com capacidade para produzir ácido quinólico e método para produzir ácido quinólico com o uso do micro-organismo
ECSDI19005744S (es) Configuración aplicada en jarra
CA158247S (en) Self injection pen device
CA161801S (en) Hybrid clock